The French pharmacist has taken legal actions against the Danish for the dissemination of false information about their vaccines.
Sanofi has filed a lawsuit in the United States against Novo Nordisk in which he accuses it of disseminating false information about the availability of French pharmaceutical vaccines in order to promote his competitor medicine.
According to the Reuters agency, Sanofi has requested an order that forces its competitor to pay for unpalified monetary damage, as well as the withdrawal of marketing materials that promote the drug of Novo Nordisk.
"Novo Nordisk's statements contain false and misleading information"
And, these brochures urge health professionals to change health diabetes medicines) As of January.
However, the affected pharmacist has explained that the CVS will not block their medications, but is promoting more economical ones within health insurance, while patients who want Sanofi will have to pay more for them.
In this sense, Sanofi has made exclusive statements to Reuters in which it ensures that "Novo Nordisk's statements about the CVS decision regarding the coverage of Lantus and Toujeo contain false and deceptive statements about their continuous availability."
Of Izd.A DRCHA: Olivier Brandicourt, CEO of Sanofi;and Lars Reiben Sørensen, CEO of Novo Nordisk.
